BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 29957488)

  • 21. PrimPol prevents APOBEC/AID family mediated DNA mutagenesis.
    Pilzecker B; Buoninfante OA; Pritchard C; Blomberg OS; Huijbers IJ; van den Berk PC; Jacobs H
    Nucleic Acids Res; 2016 Jun; 44(10):4734-44. PubMed ID: 26926109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of A-to-I RNA editing in infections by RNA viruses: Possible implications for SARS-CoV-2 infection.
    Vlachogiannis NI; Verrou KM; Stellos K; Sfikakis PP; Paraskevis D
    Clin Immunol; 2021 May; 226():108699. PubMed ID: 33639276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis.
    Taylor BJ; Nik-Zainal S; Wu YL; Stebbings LA; Raine K; Campbell PJ; Rada C; Stratton MR; Neuberger MS
    Elife; 2013 Apr; 2():e00534. PubMed ID: 23599896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of DNA cleavage- and recombination-specific hnRNP cofactors for activation-induced cytidine deaminase.
    Hu W; Begum NA; Mondal S; Stanlie A; Honjo T
    Proc Natl Acad Sci U S A; 2015 May; 112(18):5791-6. PubMed ID: 25902538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA binding to APOBEC deaminases; Not simply a substrate for C to U editing.
    Smith HC
    RNA Biol; 2017 Sep; 14(9):1153-1165. PubMed ID: 27869537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. APOBEC-mediated editing of viral RNA.
    Bishop KN; Holmes RK; Sheehy AM; Malim MH
    Science; 2004 Jul; 305(5684):645. PubMed ID: 15286366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A combined nuclear and nucleolar localization motif in activation-induced cytidine deaminase (AID) controls immunoglobulin class switching.
    Hu Y; Ericsson I; Torseth K; Methot SP; Sundheim O; Liabakk NB; Slupphaug G; Di Noia JM; Krokan HE; Kavli B
    J Mol Biol; 2013 Jan; 425(2):424-43. PubMed ID: 23183374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo.
    Suspène R; Guétard D; Henry M; Sommer P; Wain-Hobson S; Vartanian JP
    Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8321-6. PubMed ID: 15919829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiretroviral APOBEC3 cytidine deaminases alter HIV-1 provirus integration site profiles.
    Ajoge HO; Renner TM; Bélanger K; Greig M; Dankar S; Kohio HP; Coleman MD; Ndashimye E; Arts EJ; Langlois MA; Barr SD
    Nat Commun; 2023 Jan; 14(1):16. PubMed ID: 36627271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases.
    Mahieux R; Suspène R; Delebecque F; Henry M; Schwartz O; Wain-Hobson S; Vartanian JP
    J Gen Virol; 2005 Sep; 86(Pt 9):2489-2494. PubMed ID: 16099907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The APOBEC-2 crystal structure and functional implications for the deaminase AID.
    Prochnow C; Bransteitter R; Klein MG; Goodman MF; Chen XS
    Nature; 2007 Jan; 445(7126):447-51. PubMed ID: 17187054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissociation of in vitro DNA deamination activity and physiological functions of AID mutants.
    Shivarov V; Shinkura R; Honjo T
    Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15866-71. PubMed ID: 18832469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Replication catastrophe induced by cyclic hypoxia leads to increased APOBEC3B activity.
    Bader SB; Ma TS; Simpson CJ; Liang J; Maezono SEB; Olcina MM; Buffa FM; Hammond EM
    Nucleic Acids Res; 2021 Jul; 49(13):7492-7506. PubMed ID: 34197599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesoscale DNA feature in antibody-coding sequence facilitates somatic hypermutation.
    Wang Y; Zhang S; Yang X; Hwang JK; Zhan C; Lian C; Wang C; Gui T; Wang B; Xie X; Dai P; Zhang L; Tian Y; Zhang H; Han C; Cai Y; Hao Q; Ye X; Liu X; Liu J; Cao Z; Huang S; Song J; Pan-Hammarström Q; Zhao Y; Alt FW; Zheng X; Da LT; Yeap LS; Meng FL
    Cell; 2023 May; 186(10):2193-2207.e19. PubMed ID: 37098343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling the Embrace of a Mutator: APOBEC Selection of Nucleic Acid Ligands.
    Salter JD; Smith HC
    Trends Biochem Sci; 2018 Aug; 43(8):606-622. PubMed ID: 29803538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of somatic hypermutation: critical analysis of strand biased mutation signatures at A:T and G:C base pairs.
    Steele EJ
    Mol Immunol; 2009 Jan; 46(3):305-20. PubMed ID: 19062097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nucleotide Weight Matrices Reveal Ubiquitous Mutational Footprints of AID/APOBEC Deaminases in Human Cancer Genomes.
    Rogozin IB; Roche-Lima A; Lada AG; Belinky F; Sidorenko IA; Glazko GV; Babenko VN; Cooper DN; Pavlov YI
    Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30759888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apurinic/apyrimidinic endonuclease 1 (APE1) is dispensable for activation-induced cytidine deaminase (AID)-dependent somatic hypermutation in the immunoglobulin gene.
    Islam H; Kobayashi M; Honjo T
    Int Immunol; 2019 Jul; 31(8):543-554. PubMed ID: 30877298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Local sequence targeting in the AID/APOBEC family differentially impacts retroviral restriction and antibody diversification.
    Kohli RM; Maul RW; Guminski AF; McClure RL; Gajula KS; Saribasak H; McMahon MA; Siliciano RF; Gearhart PJ; Stivers JT
    J Biol Chem; 2010 Dec; 285(52):40956-64. PubMed ID: 20929867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stochastic properties of processive cytidine DNA deaminases AID and APOBEC3G.
    Chelico L; Pham P; Goodman MF
    Philos Trans R Soc Lond B Biol Sci; 2009 Mar; 364(1517):583-93. PubMed ID: 19022738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.